Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

125 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Completed

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

NCT00137969

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • Univ of Alabama School of Med; Clinical Immun Rheumatology Birmingham, Alabama, United States
  • Rheumatology Assoc of North AL Huntsville, Alabama, United States
  • Arizona Arthritis & Rheumatology Research, Pllc Paradise Valley, Arizona, United States
  • Univ of California, San Diego La Jolla, California, United States
View all 65 locations
View Trial Details
Completed

An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults

NCT01753193

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site La Palma, California, United States
  • Research Site Long Beach, California, United States
  • Research Site Los Angeles, California, United States
View all 57 locations
View Trial Details
Completed

A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

NCT02504645

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • WALLACE Los Angeles, California, United States
  • East Bay Rheumatology Medical San Leandro, California, United States
  • Denver Arthritis Clinic Denver, Colorado, United States
  • Arthritis and Rheumatic Disease Specialties Aventura, Florida, United States
View all 30 locations
View Trial Details
Completed

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

NCT03427151

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • WALLACE Los Angeles, California, United States
  • East Bay Rheumatology Medical San Leandro, California, United States
  • Arthritis and Rheumatic Disease Specialties Aventura, Florida, United States
  • Innovative Health Research Las Vegas, Nevada, United States
View all 14 locations
View Trial Details
Completed

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

NCT02437890

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • Investigator Site Birmingham, Alabama, United States
  • Investigator Site Glendale, Arizona, United States
  • Investigator Site Phoenix, Arizona, United States
  • Investigator Site Tucson, Arizona, United States
View all 118 locations
View Trial Details
Completed

Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus

NCT00714116

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • Arthritis & Rheumatology Care Center South Miami, Florida, United States
  • Miami Research Associates South Miami, Florida, United States
  • MRA Clinical Research South Miami, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions